Pharma Latest News, Photos and Videos

Trump's 50 per cent Copper Tariff And 200 per cent pharma threat

Trump’s 50 per cent copper tariff, 200 per cent pharma threat: What it means for India

World | Jul 09, 2025, 12:28 PM IST

Trump’s steep tariff warning puts India’s key exports at risk, with copper facing a 50 per cent duty and pharma staring at a possible 200 per cent hit.

Stock Under Rs 100: Shares of this pharma company rebound even as market remains volatile

Market | Jun 18, 2025, 02:16 PM IST

On the NSE, the stock started trading at Rs 54.68 and touched a high of Rs 56.22. The stock of Sigachi Industries had tanked 6.88 per cent in the last trading session.

This pharma stock below Rs 60 gains 10% as company shares global expansion - Check details

Market | Jun 09, 2025, 12:36 PM IST

The stock trades higher than the 5-day and 20-day moving averages but lower than the 50-day, 100-day and 200-day moving averages.

This pharma company gets 'One Star Export House' status from government - Here's what it means

Market | Jun 05, 2025, 03:34 PM IST

This government certification signifies that the company has demonstrated excellent performance in international trade and achieved a certain level of export performance.

Pharma stocks tumble as US President Trump signs executive order to encourage US drug manufacturing

Market | May 06, 2025, 02:54 PM IST

According to reports, the executive order signed by Trump directs the US Food and Drug Administration (USFDA) to streamline reviews and work with domestic manufacturers to provide early support before facilities come online.

Aurobindo Pharma arm gets USFDA nod for generic blood cancer drug

Market | May 10, 2025, 05:51 PM IST

Meanwhile, Asian markets, South Korea's Kospi index, Tokyo's Nikkei 225, Shanghai SSE Composite and Hong Kong's Hang Seng were trading in the positive territory.

BSE-listed pharma stock to soon announce twin corporate events of bonus and split

Business | Apr 10, 2024, 06:56 AM IST

After a successful rights issue earlier this year, the company aims to further enhance shareholder value and improve market accessibility through these strategic moves

Budget 2024: Pharma industry seeks incentives to boost R&D, eyes USD 400-450 billion market size

Business | Jan 15, 2024, 12:27 PM IST

The pharmaceutical industry aims to reach $120-130 billion by 2030 and further elevate to $400-450 billion by 2047 by calling for increased focus on innovation and expedited research and development efforts.

Sensex, Nifty record marginal declines as financial markets remain dynamic

Business | Nov 07, 2023, 04:00 PM IST

These fluctuations highlight the ongoing dynamics in India's financial landscape, with investors keenly observing these movements and their potential implications for the market.

Pharma stock Sigachi Industries to consider sub-division of equity shares as Sensex, Nifty scale hig

Business | Jul 18, 2023, 06:52 AM IST

According to BSE, pharmaceuticals major Sigachi Industries has said that the board is likely to announce the sub-division of equity shares. Its board will meet on August 2 to consider the sub-division of equity shares of face value of Rs 10.

Buildings, plant and machinery of the company, Surya

ED attaches Rs 185 crore worth of assets of Surya Pharmaceuticals

India | Oct 18, 2022, 05:44 PM IST

The money laundering case stems from two CBI FIRs, filed on the complaint of State Bank of India (SBI), Chandigarh and Punjab and Sind Bank, Karnal, against the company and its managing director.

SP Singh Chawla, Trrust Health Care, pharma sector

Working towards a healthier world

Brand Content | Jun 14, 2022, 08:36 PM IST

Set up by SP Singh Chawla in 1995, Trrust Health Care is a leading pharmaceutical company, which is providing safe, effective and reliable pharmaceuticals to its clients in India and abroad

Japanese drugmaker, japan company to launch, plant based COVID vaccine, latest international coronav

Japanese drugmaker to launch first-ever plant-based COVID vaccine

World | Oct 13, 2021, 02:48 PM IST

The vaccine technology is formed with virus-like particles that mimic the target virus and does not actually use a live virus, unlike some of the current vaccines and can thus be deemed relatively safe for humans.

Equity indices flat, IT and pharma scrips gain

News | Aug 17, 2021, 02:33 PM IST

Equity benchmark gauges were at flat levels during early hours on Tuesday amid slim gains in Asian markets with investors concerned about the outlook of global macroeconomic data after the spread of COVID-19 virus. At 10:15 am, the BSE SandP Sensex was down by 30 points or 0.05 per cent at 55,553 while the Nifty 50 moved lower by 5 points or 0.03 per cent to 16,558.

Pharma